Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.
Jeil Pharma Dividend Announcement
• Jeil Pharma announced a annually dividend of ₩50.00 per ordinary share which will be made payable on 2025-04-18. Ex dividend date: 2024-12-27
• Jeil Pharma annual dividend for 2024 was ₩50.00
• Jeil Pharma annual dividend for 2023 was ₩50.00
• Jeil Pharma's trailing twelve-month (TTM) dividend yield is 0.58%
• Jeil Pharma's payout ratio for the trailing twelve months (TTM) is -0.87%
• Jeil Pharma's dividend growth over the last five years (2018-2023) was -6.51% year
• Jeil Pharma's dividend growth over the last ten years (2013-2023) was 2.26% year
Jeil Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | ₩50.00 | annually | 2025-04-18 |
2023-12-27 | ₩50.00 | annually | 2024-04-18 |
2022-12-28 | ₩50.00 | annually | 2023-04-19 |
2021-12-29 | ₩65.00 | annually | 2022-04-21 |
2020-12-29 | ₩70.00 | annually | 2021-04-22 |
2019-12-27 | ₩70.00 | annually | 2020-04-23 |
2018-12-27 | ₩70.00 | annually | 2019-04-18 |
2017-12-27 | ₩60.00 | annually | 2018-04-19 |
2016-12-28 | ₩70.00 | annually | |
2015-12-29 | ₩60.00 | annually | |
2014-12-29 | ₩60.00 | annually | |
2013-12-27 | ₩40.00 | annually |
Jeil Pharma Dividend per year
Jeil Pharma Dividend growth
Jeil Pharma Dividend Yield
Jeil Pharma current trailing twelve-month (TTM) dividend yield is 0.58%. Interested in purchasing Jeil Pharma stock? Use our calculator to estimate your expected dividend yield:
Jeil Pharma Financial Ratios
Jeil Pharma Dividend FAQ
Other factors to consider when evaluating Jeil Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Jeil Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Jeil Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Jeil Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Jeil Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Jeil Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Jeil Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Jeil Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Jeil Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Jeil Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Jeil Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.